FNPFX | SGACX | FNPFX / SGACX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 11 years | - |
Gain YTD | 21.878 | 13.741 | 159% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 149B | 305M | 48,852% |
Annual Yield % from dividends | 1.11 | 0.00 | - |
Returns for 1 year | 23.54 | 14.80 | 159% |
Returns for 3 years | 8.06 | -3.14 | -257% |
Returns for 5 years | 42.43 | 27.17 | 156% |
Returns for 10 years | N/A | 96.22 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNSX | 66.38 | 0.06 | +0.09% |
Janus Henderson Global Life Sciences S | |||
MABBX | 10.08 | N/A | N/A |
Morgan Stanley US Focus Real Estate C | |||
MBLAX | 13.01 | -0.03 | -0.23% |
Madison Diversified Income A | |||
UOPIX | 126.13 | -1.12 | -0.88% |
ProFunds UltraNASDAQ-100 Inv | |||
MSCDX | 18.41 | -0.23 | -1.23% |
MassMutual Small Cap Opps R5 |